Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 24.45
-0.35 (-1.41%)
At close: Jan 20, 2026
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 10.1 billion as of January 22, 2026. Its market cap has increased by 20.40% in one year.
Market Cap
10.10B
Enterprise Value
10.48B
Revenue
845.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.45
Market Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 10.10B, a decrease of -59.50%. That is a compound annual growth rate of -14.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 10.10B | 5.36% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 305.26B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 126.75B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.32B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |